FDA Inspection 1235010 — Delpharm Tours
The FDA completed an inspection of Delpharm Tours on June 11, 2021 in Chambray Les Tours. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 11, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chambray Les Tours (France)
Additional Details
Mutual Recognition Agreement (MRA)